Nature Communications · 2015 · 124 citations · 28 references
MedicineOncologyPharmacologyCarcinogenesisCell SignalingMolecular OncologyBreast Cancer PharmacotherapyCancer GenomicsTherapeutic ResistanceBreast Cancer Resistance MechanismsGlucocorticoid ReceptorsGlucocorticoid SignalingLigand-dependent RegulationLigand-dependent Transcriptional RegulationMolecular Drug ResistancePro-tumorigenic SignalingTriple-negative Breast Cancer Therapy
Glucocorticoids (GCs) have been widely used as coadjuvants in the treatment of solid tumours, but GC treatment may be associated with poor pharmacotherapeutic response or prognosis. The genomic action of GC in these tumours is largely unknown. Here we find that dexamethasone (Dex, a synthetic GC)-regulated genes in triple-negative breast cancer (TNBC) cells are associated with drug resistance. Importantly, these GC-regulated genes are aberrantly expressed in TNBC patients and are associated with unfavourable clinical outcomes. Interestingly, in TNBC cells, Compound A (CpdA, a selective GR modulator) only regulates a small number of genes not involved in carcinogenesis and therapy resistance. Mechanistic studies using a ChIP-exo approach reveal that Dex- but not CpdA-liganded glucocorticoid receptor (GR) binds to a single glucocorticoid response element (GRE), which drives the expression of pro-tumorigenic genes. Our data suggest that development of safe coadjuvant therapy should consider the distinct genomic function between Dex- and CpdA-liganded GR.
28
MEME SUITE: tools for motif discovery and searching
Timothy L. Bailey, Mikael Bodén, Fabian A. Buske et al. · Nucleic Acids Research · 2009 · 11.5K citations · Full text
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin et al. · Nature · 2012 · 6.4K citations · Full text
Life Sciences, Genetics, Oncology +14
GREAT improves functional interpretation of cis-regulatory regions
Cory Y. McLean, Dave Bristor, Michael Hiller et al. · Nature Biotechnology · 2010 · 5K citations